Marquam Hill Lectures
Since 1981, the Marquam Hill Lecture Series has brought together leading members of the OHSU faculty with the public for free lectures which feature innovative and cutting edge biomedical research and clinical advances that will form the basis of tomorrow's cures and treatments.
The Marquam Hill Lecture Series is one of the most popular and long-standing lecture series about science by scientists in Oregon. The series honors the memory of Mrs. Elizabeth Gray, co-founder of the Marquam Hill Steering Committee, a group of community leaders who advocate for the public missions of OHSU throughout the state. In addition to oversight of the Marquam Hill Lectures, the Committee selects and maintains the extensive collection of art in OHSU buildings, and curated Art on the Hill, a book of works from the OHSU collection.
2017–18 lecture series
Sweat Smart: What Sports Medicine Science Tells Us about Effective – and Safe – Exercise
Douglas B. McKeag, M.D., M.S., F.A.C.S.M.
Whether you're an athlete, a weekend warrior or an active retiree, sports medicine science has come a long way in discovering the do's and don'ts of injury-free fitness. Douglas B. McKeag M.D., M.S., F.A.C.S.M., adjunct instructor of Family Medicine, OHSU School of Medicine, shares insights on such current topics as concussion risk on the playing field;high-intensity interval training (HIIT) and how to keep your knees going as long as you do. Dr. McKeag, a pioneer in primary care sports medicine, founding director of the Indiana University Center for Sports Medicine and longtime chair of family medicine at IU School of Medicine, is an OHSU-affiliated instructor who has served as a consultant to the 2000 Sydney and 2008 Beijing Olympic Committees and an expert source for such publications as Sports Illustrated and ESPN, Dr. McKeag is known for his factual and informative presentations.
The promise of early cancer detection
Sadik Esener, Ph.D.
Thursday, Nov. 16, 2017 at 7 p.m.
OHSU Auditorium, Marquam Hill Campus
Register to attend
National Cancer Institute data shows that cancer patients' five-year survival rate approaches 99 percent if the disease is detected at stage 1. The challenge: many cancers detected early are not actually lethal –yet current detection approaches can't tell us which are or aren't, so patients too often get unnecessary, sometimes risky, therapies that impact their quality of life. Sadik Esener, Ph.D., is building a multidisciplinary team to reveal the evolutionary biology of cancer to develop low-cost screening, determine which cancers to aggressively treat and leverage precision therapies to minimize toxicity. The Wendt Family Chair professor of biomedical engineering in the OHSU School of Medicine and director of the Knight Cancer Institute Cancer Early Detection Advanced Research Center (CEDAR), Dr. Esener and his team's goal is to find and eliminate lethal cancers at the earliest stage with little harm to the patient.
Your zip code/your health: Understanding and overcoming the social determinants of health
David Bangsberg, M.D., M.P.H.
Note that this lecture is the second, not the third, Thursday.
David Bangsberg, M.D., M.P.H., founding dean of the OHSU-PSU School of Public Health, takes us on his personal and scholarly journey from Lincoln High School Class of 1981 in Portland to medical school in Baltimore, residency in New York City, fellowship in San Francisco, professorship in Cambridge, MA and visiting professorship in rural Uganda. Caring for people suffering from HIV/AIDS, addiction and homelessness, he learned the extent to which where you are born and the social climate around you determines your health. For Dr. Bangsberg, returning to Portland to lead the new OHSU-PSU School of Public Health is making good on his commitment to change that paradigm.
Cracking the code of advanced prostate cancer
Joshi J. Alumkal, M.D.
Prostate cancer is the third-leading cause of cancer-related death in men in the United States. Not all prostate cancers are the same, and we now know more than ever about how the blueprint –or code –of prostate cancer cells differs from normal cells. Understanding which differences in this blueprint are most important for cancer aggressiveness and treatment decision-making will be the focus of Dr. Joshi Alumkal's lecture. Dr. Alumkal is an associate professor of medicine in the OHSU School of Medicine and co-leader of the OHSU Knight Cancer Institute Prostate Cancer Research Program. In this lecture, Dr. Alumkal will discuss how engaging patients as partners has significantly improved our ability to understand the blueprint of advanced prostate cancer and to develop new treatments to control advanced prostate cancer more effectively.
In the interest of serving all Oregonians, each Marquam Hill Lecture is recorded. Watch past years' lectures here.